Group One Trading’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,509
Closed -$465K 9042
2021
Q4
$542K Sell
1,509
-300
-17% -$101K ﹤0.01% 4042
2021
Q3
$589K Sell
1,809
-144
-7% -$48.8K ﹤0.01% 4005
2021
Q2
$610K Buy
1,953
+1,063
+119% +$326K ﹤0.01% 3996
2021
Q1
$284K Sell
890
-18
-2% -$5.76K ﹤0.01% 4643
2020
Q4
$294K Sell
908
-1,400
-61% -$387K ﹤0.01% 3758
2020
Q3
$639K Buy
+2,308
New +$665K ﹤0.01% 2628
2020
Q1
Sell
-15,992
Closed -$2.65M 5933
2019
Q4
$2.73M Sell
15,992
-245
-2% -$45.4K 0.02% 1049
2019
Q3
$2.89M Buy
16,237
+1,748
+12% +$378K 0.02% 928
2019
Q2
$3.77M Buy
14,489
+11,241
+346% +$2.98M 0.03% 684
2019
Q1
$928K Sell
3,248
-375
-10% -$125K 0.01% 1460
2018
Q4
$1.18M Sell
3,623
-2,337
-39% -$812K 0.01% 1387
2018
Q3
$2.68M Buy
5,960
+3,343
+128% +$1.32M 0.02% 945
2018
Q2
$1.07M Buy
2,617
+2,157
+469% +$781K 0.01% 1664
2018
Q1
$134K Sell
460
-2,332
-84% -$591K ﹤0.01% 3070
2017
Q4
$523K Buy
2,792
+2,690
+2,637% +$502K ﹤0.01% 2217
2017
Q3
$17K Buy
102
+41
+67% +$6.2K ﹤0.01% 4136
2017
Q2
$9K Sell
61
-803
-93% -$108K ﹤0.01% 4254
2017
Q1
$108K Buy
864
+600
+227% +$69.5K ﹤0.01% 2925
2016
Q4
$30K Sell
264
-4,200
-94% -$487K ﹤0.01% 3534
2016
Q3
$574K Buy
+4,464
New +$535K 0.01% 1716
2016
Q2
Sell
-528
Closed -$50K 5041
2016
Q1
$50K Sell
528
-5,763
-92% -$486K ﹤0.01% 3254
2015
Q4
$568K Buy
+6,291
New +$534K 0.01% 1721
2015
Q3
Sell
-455
Closed -$30K 5316
2015
Q2
$30K Buy
+455
New +$30.2K ﹤0.01% 3840
2015
Q1
Sell
-13,082
Closed -$498K 5332
2014
Q4
$498K Buy
13,082
+12,700
+3,325% +$401K 0.01% 1562
2014
Q3
$9K Buy
+382
New +$9.68K ﹤0.01% 4525

Other funds holding ABMD

Group One Trading's ABMD Position: Q1 2022 in Review

Group One Trading sold out of Abiomed Inc (ABMD) in Q1 2022, closing a stake of 1,509 shares — an estimated $465K sold.

Group One Trading first reported a position in ABMD in Q3 2014 and held it in 25 quarters. The position peaked at $3.77M in Q2 2019. 500 funds tracked by Wall St. Rank hold ABMD as of Q1 2022.

  • Group One Trading reported no remaining Abiomed Inc position as of Q1 2022 after selling out during the quarter.
  • Group One Trading sold 1,509 Abiomed Inc shares in Q1 2022, an estimated $465K.
  • Group One Trading first reported a position in Abiomed Inc in Q3 2014 and held it in 25 quarters.
  • Group One Trading's Abiomed Inc position peaked at $3.77M in Q2 2019.
  • 500 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2022.

Based on Group One Trading's 13F filing for Q1 2022, filed 12 May 2022.